Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.05.24.655910

Unraveling novel insights into dual-species cariogenic biofilm formation: a comparative analysis on natural vs artificial bioengineered dentin models

Abstract

Dental caries is the most prevalent biofilm-associated disease affecting billions of people worldwide, including elderly individuals. Conventional biofilm study methods rely on human or animal-derived samples, posing challenges regarding accessibility, cost, and ethical considerations. While in-vitro systems offer a promising alternative, they often fail to replicate the structural characteristics of dentin, which play a crucial role in bacterial adhesion. To bridge this gap, a bioengineered dentin-like construct has recently been developed as a reproducible and accessible model for studying biofilm formation associated with dental aging. Therefore, this study aimed to assess dual-species Streptococcus mutans and Candida albicans biofilm formation on bioengineered dentin substrates and compare it to biofilm formation on natural human aged dentin. For this, S. mutans UA159 and C. albicans (ATCC 90028) were co-cultured on bioengineered and natural dentin slabs, and polymicrobial biofilm formation and EPS production were characterized via high-resolution confocal laser scanning microscopy. Following biofilm formation, image processing was conducted using COMSTAT software to determine biofilm growth parameters. Additionally, fluorescence intensity was quantified via microplate readings, and cell viability was assessed using a Live/Dead viability kit. Overall, results showed similar biofilm formation patterns between the bioengineered and aged dentin, with no significant differences found in biofilm physical properties or viability. These findings suggest that this bioengineered dentin system provides a reliable platform for studying biofilm formation in the context of dental aging, making it a valuable tool for investigating microbial adhesion and cariogenic biofilm development under controlled conditions, potentially facilitating future research in biofilm-related oral diseases. ImportanceDental caries is one of the most common chronic diseases worldwide, which is driven by complex microbial biofilms formed on the tooths surface. However, existing models for studying these biofilms in the laboratory often rely on human or animal tissues, which are difficult to obtain and standardize, and present ethical challenges. In this study, we validate a bioengineered dentin-like model that accurately mimics the microarchitecture of aged human dentin, a key site for root caries in the elderly. By comparing biofilms formed by the clinically significant Streptococcus mutans and Candida albicans on both artificial and natural substrates, we show that the engineered model supports biofilm development under comparable parameters and enables detection of changes in microbial virulence. Overall, this platform provides a reproducible and scalable alternative for studying oral biofilms with potential applications in understanding disease pathogenesis, novel treatment testing, and integration into next-generation organ-on-a-chip systems.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ortiz, J., Alvarez, S., Aguayo, S.. 2025-05-29. Unraveling novel insights into dual-species cariogenic biofilm formation: a comparative analysis on natural vs artificial bioengineered dentin models. https://doi.org/10.1101/2025.05.24.655910

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

SpiraMed: A Stereotactic Helix-based Therapy Delivery system for the Human Brain

Stereotactic needle-based delivery remains the standard for local administration of Advanced Therapy Medicinal Products (ATMPs) to the human brain. ATMP administration typically involves multiple trajectories, presenting cumulative risks and prolonging surgery. Reflux-prone, patchy therapy coverage compromises clinical results. We demonstrate a novel approach, deploying a helical delivery catheter via a single access trajectory per target, referred to as SpiraMed. Helix retraction is synchronised with therapy delivery, enabling comprehensive target coverage in seconds. Helix pitch and diameter can be precisely tailored to patient-specific target volume and vascular anatomy, as part of the preoperative stereotactic surgical planning process. Testing in agarose phantoms, live sheep and cadaveric human brain confirms enhanced therapy delivery volume, delivery speed and target coverage, with reductions in reflux and predicted risk of bleeding complication. SpiraMed represents a new paradigm, promising to help deliver on the transformative potential of cell and gene therapies across the spectrum of human CNS disease.

bioengineering↗

Normative Modeling of Molecular-Enriched Functional Connectivity for Detecting Deviations from Healthy Brain Aging

Inter-individual variability in adult brain aging can obscure early pathological alterations and is only partly represented by population-average or scalar brain-aging measures. We combined Receptor-Enriched Analysis of functional Connectivity by Targets (REACT) with normative modeling (NM) to derive spatially resolved, molecularly informed deviation scores for dopamine transporter (DAT)-, norepinephrine transporter (NET)-, and serotonin transporter (SERT)-enriched resting-state functional connectivity (FC). We first evaluated whether these normative models could be transferred to independently processed external data through local calibration and then explored whether the resulting deviation profiles differed with cerebral amyloid burden in cognitively unimpaired older adults. Hierarchical Bayesian regression (HBR) models with a SHASHb likelihood were estimated separately for 204 cortical molecular-enriched FC features in 4,152 healthy adults (18.0--89.8 years) from seven publicly available neuroimaging datasets and evaluated in a held-out healthy test set. Pretrained models were locally adapted to three AMYPAD-PNHS acquisition batches using cognitively unimpaired, amyloid-negative participants (global Clinical Dementia Rating [CDR] = 0; Centiloid [CL] [lt] 10). The independent primary comparison contrasted participants with intermediate amyloid burden (10 [≤] CL [lt] 30; n = 111) and amyloid-positive participants (CL [≥] 30; n = 66); secondary analyses tested linear associations with continuous CL within participants with CL [≥] 10. Of 204 normative reference models, 199 (97.5%) met the predefined diagnostic criteria; median held-out explained variance (EXPV) was 0.174. Of 612 feature-by-batch transfers, 541 (88.4%) met the strict transfer-diagnostic criteria. In the primary false discovery rate (FDR)-controlled regional analysis, DAT-enriched right caudal middle frontal cortex showed lower locally standardized deviation scores in the intermediate-amyloid-burden group than in the amyloid-positive group (adjusted difference = -0.582, q = 0.016). DAT extreme-deviation burden was also greater in the intermediate-amyloid-burden group (difference = 0.032, q = 0.044). The right frontal effect was reproduced with model-native scores across the three acquisition batches (pooled standardized effect = -0.698, q = 0.010). No NET- or SERT-enriched regional difference between these two groups survived FDR correction, and no regional or subject-level linear association with continuous CL values survived FDR correction in the CL [≥] 10 group. Normative modeling can provide spatially resolved reference distributions of molecular-enriched FC that are deployable in independently processed external data when local adaptation, calibration, and feature-level transfer diagnostics are incorporated. The AMYPAD-PNHS application identified modest, spatially selective, and molecular-system-specific categorical differences during a cognitively unimpaired stage of amyloid accumulation, while continuous analyses within CL [≥] 10 did not support a linear association. These findings support a methodological basis for distributed application of molecular-enriched normative models and motivate independent and longitudinal evaluation of their biological relevance.

bioengineering↗

AC-Diff: Anatomy-Contrast Disentangled Diffusion for Multi-Vendor Liver MRI Harmonization

Magnetic resonance imaging (MRI) exhibits substantial scanner and protocol dependent appearance variations, making harmonization challenging without distorting patient specific anatomy, particularly in abdominal imaging. We propose AC-Diff, an anatomy--contrast disentangled diffusion framework that formulates MRI harmonization as a factor-specific generative intervention. Using aligned multi-contrast supervision and cross-patient factor swapping, AC-Diff learns to separate anatomical structure from acquisition-dependent contrast. Unlike conventional image or latent diffusion, AC-Diff restricts stochastic generation to the contrast subspace while the source anatomy bypasses diffusion and is directly reused during reconstruction. Experiments on an in-house multi-vendor cohort and the external Duke Liver MRI dataset demonstrate improved target-domain alignment with strong structural preservation. In downstream liver segmentation, AC-Diff improves Dice from 0.942 for the original inputs to 0.954 for the harmonized images. These results support contrast-specific latent generation as a promising approach to anatomy-preserving MRI harmonization.

bioengineering↗